Neurobo Pharmaceuticals Stock Target Price and Analyst Consensus

NRBO Stock  USD 2.40  0.05  2.04%   
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Neurobo Pharmaceuticals price targets

Neurobo Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Neurobo Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Neurobo Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Neurobo Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Neurobo Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Neurobo Pharmaceuticals is a key component of Neurobo Pharmaceuticals valuation and have some predictive power on the future returns of a Neurobo Pharmaceuticals.
Hype
Prediction
LowEstimatedHigh
0.122.407.29
Details
Intrinsic
Valuation
LowRealHigh
0.112.257.14
Details
Naive
Forecast
LowNextHigh
0.052.327.21
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.242.633.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Neurobo Pharmaceuticals. Your research has to be compared to or analyzed against Neurobo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Neurobo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Neurobo Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Gambling Idea
Gambling
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
FinTech Idea
FinTech
Invested over 40 shares
Momentum Idea
Momentum
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
When determining whether Neurobo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurobo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurobo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurobo Pharmaceuticals Stock:
Check out Macroaxis Advice on Neurobo Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Neurobo Stock, please use our How to Invest in Neurobo Pharmaceuticals guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.